The sphingomyelin cycle and the second messenger function of ceramide
- PMID: 8106344
The sphingomyelin cycle and the second messenger function of ceramide
Similar articles
-
The therapeutic potential of modulating the ceramide/sphingomyelin pathway.J Clin Invest. 2002 Jul;110(1):3-8. doi: 10.1172/JCI16127. J Clin Invest. 2002. PMID: 12093880 Free PMC article. Review. No abstract available.
-
Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor.Science. 1994 Sep 9;265(5178):1596-9. doi: 10.1126/science.8079174. Science. 1994. PMID: 8079174
-
Ceramides and sphingomyelins in skeletal muscles of the rat: content and composition. Effect of prolonged exercise.Am J Physiol Endocrinol Metab. 2002 Feb;282(2):E277-85. doi: 10.1152/ajpendo.00151.2001. Am J Physiol Endocrinol Metab. 2002. PMID: 11788358
-
Ceramide: a novel second messenger.Adv Lipid Res. 1993;25:65-90. Adv Lipid Res. 1993. PMID: 8368154 Review.
-
Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system.Science. 1992 Mar 27;255(5052):1715-8. doi: 10.1126/science.1313189. Science. 1992. PMID: 1313189
Cited by
-
Ablation of dihydroceramide desaturase confers resistance to etoposide-induced apoptosis in vitro.PLoS One. 2012;7(9):e44042. doi: 10.1371/journal.pone.0044042. Epub 2012 Sep 11. PLoS One. 2012. PMID: 22984457 Free PMC article.
-
Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection.PLoS Pathog. 2010 Sep 23;6(9):e1001109. doi: 10.1371/journal.ppat.1001109. PLoS Pathog. 2010. PMID: 20886096 Free PMC article.
-
Biochemical studies on sphingolipid of Artemia franciscana (I) isolation and characterization of sphingomyelin.Lipids. 2010 Jul;45(7):635-43. doi: 10.1007/s11745-010-3438-8. Epub 2010 Jun 24. Lipids. 2010. PMID: 20571930
-
Involvement of the ceramide signaling pathway in modulating the differentiated state of porcine thyroid cells.Lipids. 2000 Nov;35(11):1259-68. doi: 10.1007/s11745-000-0642-7. Lipids. 2000. PMID: 11132185
-
A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosis.PLoS One. 2009 Sep 9;4(9):e6938. doi: 10.1371/journal.pone.0006938. PLoS One. 2009. PMID: 19742320 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources